RBC Updated Price Target, Estimates for RWE on Amprion Stake Deal, Equity Raise
RBC Capital Markets revised its price target and earnings projections for RWE (RWE.F) following the German energy company's deal to increase its stake in the transmission system operator Amprion and the associated equity raise. "The Amprion acquisition adds a [high-growth network], increasing RWE's share of regulated earnings. Elsewhere, we see opportunities from gas tenders, power demand growth, AR8 and a potential lease agreement with the US government," the research firm said Thursday. Analysts noted that the utility is still in negotiations with the US government over three paused offshore wind leases, with $1 billion of investments. A settlement agreement would allow RWE to divert these funds into productive US generation projects. Against this backdrop, RBC raised the outperform-rated stock's price target to 65 euros from 62.50 euros. Analysts also tweaked their EBITDA forecasts, lifting their full-year 2027 and 2028 assumptions with their 2026 projection unchanged, while lowering their adjusted EPS estimates for 2026 and 2027, then raising them for 2028. "We believe there is significant opportunity for value accretion for RWE, see Amprion as a positive investment and.
RBC Capital Markets revised its price target and earnings projections for RWE (RWE.F) following the German energy company's deal to increase its stake in the transmission system operator Amprion and the associated equity raise. "The Amprion acquisition adds a [high-growth network], increasing RWE's share of regulated earnings.
Elsewhere, we see opportunities from gas tenders, power demand growth, AR8 and a potential lease agreement with the US government," the research firm said Thursday.
Analysts noted that the utility is still in negotiations with the US government over three paused offshore wind leases, with $1 billion of investments.
A settlement agreement would allow RWE to divert these funds into productive US generation projects.
Against this backdrop, RBC raised the outperform-rated stock's price target to 65 euros from 62.50 euros.
Analysts also tweaked their EBITDA forecasts, lifting their full-year 2027 and 2028 assumptions with their 2026 projection unchanged, while lowering their adjusted EPS estimates for 2026 and 2027, then raising them for 2028. "We believe there is significant opportunity for value accretion for RWE, see Amprion as a positive investment and.